[go: up one dir, main page]

PT100973A - Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica - Google Patents

Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica

Info

Publication number
PT100973A
PT100973A PT100973A PT10097392A PT100973A PT 100973 A PT100973 A PT 100973A PT 100973 A PT100973 A PT 100973A PT 10097392 A PT10097392 A PT 10097392A PT 100973 A PT100973 A PT 100973A
Authority
PT
Portugal
Prior art keywords
transdermic
melatonin
administration
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
PT100973A
Other languages
English (en)
Inventor
Lina T Taskovich
Su Il Yum
F Eugene Yates
Nieves Marzan Crisologo
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT100973A publication Critical patent/PT100973A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
PT100973A 1991-10-18 1992-10-16 Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica PT100973A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77921591A 1991-10-18 1991-10-18

Publications (1)

Publication Number Publication Date
PT100973A true PT100973A (pt) 1994-06-30

Family

ID=25115696

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100973A PT100973A (pt) 1991-10-18 1992-10-16 Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica

Country Status (11)

Country Link
US (1) US5508039A (pt)
EP (1) EP0608362A1 (pt)
JP (1) JPH07503232A (pt)
AU (1) AU660336B2 (pt)
CA (1) CA2116036A1 (pt)
FI (1) FI941761A0 (pt)
MX (1) MX9205981A (pt)
NZ (1) NZ244760A (pt)
PT (1) PT100973A (pt)
WO (1) WO1993007870A1 (pt)
ZA (1) ZA928011B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5591768A (en) * 1990-12-04 1997-01-07 State Of Oregan, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Methods for treating circadian rhythm phase disturbances
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
DE69401945T3 (de) 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
FR2751539B1 (fr) * 1996-07-25 1998-12-04 Oreal Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
CA2345492C (en) * 1998-09-29 2009-12-22 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
DK1272177T3 (da) * 2000-01-05 2007-08-06 Neurim Pharma 1991 Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US20030021836A1 (en) * 2001-04-20 2003-01-30 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
DE10154324A1 (de) * 2001-11-06 2003-08-07 Merz Pharma Gmbh & Co Kgaa Topisch applizierbare Zusammensetzungen mit externer Wirkstoffdepotbildung, deren Herstellung sowie deren Verwendung
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents
EP1667678B1 (en) 2003-10-03 2009-05-06 Veijlen N.V. Animal feed composition
CN1938018B (zh) * 2003-10-03 2010-09-01 维伊林股份有限公司 化合物在制备治疗与降低的igf-1血清水平有关的人和动物的各种疾病状况的组合物中的用途
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
EP2124907B1 (en) 2007-03-19 2018-05-30 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin b12
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
JP5794911B2 (ja) * 2008-03-27 2015-10-14 ネステク ソシエテ アノニム ペプチド、ペプチド模倣体及び他の胃腸内輸送タンパク質基質の吸収を増加する方法
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
MX2011011698A (es) 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
EP3116489A4 (en) * 2014-03-10 2018-02-21 Yu, Benjamin M. Methods and compositions for transdermal delivery
US10744122B2 (en) * 2015-02-04 2020-08-18 Soeur Josefa Menendez Transdermal therapeutic system containing valentonin and use thereof as a medicament
KR102499141B1 (ko) * 2016-10-31 2023-02-13 신신제약 주식회사 수면장애 치료용 경피흡수제제
EP3743131B1 (en) * 2018-01-25 2025-03-05 Circadian Positioning Systems, Inc. Patch system for monitoring and enhancing sleep and circadian rhythm alignment
US20200121507A1 (en) * 2018-10-18 2020-04-23 Moldex-Metric, Inc. Foam earplug with transdermal material
SE544626C2 (en) * 2020-03-05 2022-09-27 Nub Group Ab An earplug for administering a fluid agent into an ear canal

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4296324A (en) * 1979-11-02 1981-10-20 Santa Barbara Research Center Dual spectrum infrared fire sensor
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4849226A (en) * 1981-06-29 1989-07-18 Alza Corporation Method for increasing oxygen supply by administering vasodilator
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
IT1187676B (it) * 1985-07-03 1987-12-23 Montefluos Spa Processo per la lubrificazione di organi accessori di cassette contenenti nastri magnetici
GB8517958D0 (en) * 1985-07-16 1985-08-21 Cellena Cell Eng Ag Compositions containing melatonin/homologues
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
EP0249343B1 (en) * 1986-06-13 1992-01-08 Alza Corporation Moisture activation of transdermal drug delivery system
IL79264A0 (en) * 1986-06-27 1986-09-30 Univ Ramot Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US5049387A (en) * 1987-03-09 1991-09-17 Alza Corporation Inducing skin tolerance to a sensitizing drug
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
EP0375726A4 (en) * 1987-08-17 1991-01-30 Whitby Research Incorporated Melatonin analogues
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US4948103A (en) * 1989-01-30 1990-08-14 Illinois Tool Works, Inc. Spring-loaded dampening actuator
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders

Also Published As

Publication number Publication date
FI941761A7 (fi) 1994-04-15
US5508039A (en) 1996-04-16
AU660336B2 (en) 1995-06-22
WO1993007870A1 (en) 1993-04-29
NZ244760A (en) 1997-02-24
FI941761L (fi) 1994-04-15
CA2116036A1 (en) 1993-04-29
FI941761A0 (fi) 1994-04-15
MX9205981A (es) 1993-04-01
EP0608362A1 (en) 1994-08-03
JPH07503232A (ja) 1995-04-06
AU2877892A (en) 1993-05-21
ZA928011B (en) 1993-06-23

Similar Documents

Publication Publication Date Title
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
FI940787A7 (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
MX9101175A (es) Composicion farmaceutica para administracion nasal
FI955907A7 (fi) Laite farmaseuttisten aineiden antamiseksi
FI940850A7 (fi) Laite lääkkeen annostelemiseksi ihon kautta
IT233201Y1 (it) Dispositivo a due componenti per la somministrazione di farmaci
DK0585252T3 (da) Farmaceutiske formuleringer
KR950700754A (ko) 신규의 약물(novel medicament)
ATA129892A (de) Pharmazeutische zusammensetzung
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
DK0515312T3 (da) Farmaceutisk præparat
IT9020025A0 (it) Dispositivo per la somministrazione di sostanze medicamentose in polvere
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
PT100814A (pt) Formulacoes transdermica para a administracao de prazosina
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DE4294862T1 (de) Pharmazeutische Komposition
MX9200146A (es) Composiciones farmaceuticas deglutibles
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ITMI922885A1 (it) Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
DK0511991T3 (da) Farmaceutisk formulering
IT217359Z2 (it) Dispositivo di somministrazione di farmaci

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19940106

FC3A Refusal

Effective date: 19990518